WallStreetZenWallStreetZen

NASDAQ: PTPI
Petros Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for PTPI

Based on 1 analyst offering 12 month price targets for Petros Pharmaceuticals Inc.
Min Forecast
$4.00+515.38%
Avg Forecast
$4.00+515.38%
Max Forecast
$4.00+515.38%

Should I buy or sell PTPI stock?

Based on 1 analyst offering ratings for Petros Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PTPI stock forecasts and price targets.

PTPI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-08

1 of 1

PTPI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
PTPI$0.65$4.00+515.38%Strong Buy
CPHI$0.32N/AN/A
EVOK$0.46N/AN/A
YCBD$0.98N/AN/A
SNOA$0.16N/AN/A

Petros Pharmaceuticals Stock Forecast FAQ

Is Petros Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PTPI) stock is to Strong Buy PTPI stock.

Out of 1 analyst, 1 (100%) are recommending PTPI as a Strong Buy, 0 (0%) are recommending PTPI as a Buy, 0 (0%) are recommending PTPI as a Hold, 0 (0%) are recommending PTPI as a Sell, and 0 (0%) are recommending PTPI as a Strong Sell.

If you're new to stock investing, here's how to buy Petros Pharmaceuticals stock.

What is PTPI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PTPI price target, the average PTPI price target is $4.00, with the highest PTPI stock price forecast at $4.00 and the lowest PTPI stock price forecast at $4.00.

The Wall Street analyst predicted that Petros Pharmaceuticals's share price could reach $4.00 by Dec 8, 2024. The average Petros Pharmaceuticals stock price prediction forecasts a potential upside of 515.38% from the current PTPI share price of $0.65.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.